带有
水杨基
苯并恶唑配体2a - 2f [L = R-2-(苯并[d]
恶唑-2-基)-
苯酚 (R = H ( 2a ), R = 6-CH 3 ( 2b) ), R = 6- t Bu ( 2c ), R = 4-OCH 3 ( 2d ), R = 4-Cl ( 2e ), R = 4-NO 2 ( 2f )] 和
水杨基
苯并噻唑配体3a - 3f [L = R-2-(benzo[d]xazol-2-yl)-phenol (R = H ( 3a ), R = 6-CH 3 ( 3b ), R = 6- t Bu ( 3c ), R = 4-OCH 3( 3d ), R = 4-Cl ( 3e ), R = 4-NO 2 ( 3f )]是通过CpCrCl 2 (THF)和相应
配体的钠盐在-78℃下在THF中的脱盐反应合成的℃。配合物3a和3e的分子结构由单晶 X 射线晶体学分析证实。在少量AlEt